Stocks
Neurocrine Biosciences (NBIX) ROA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | 2.83% | 23.5% | 4.32% | 6.52% | 7.68% | 10.9% | ||
| Changes by years, y/y, % | +1pp | +21pp | -19pp | +2pp | +1pp | +29.3% | |||
Neurocrine Biosciences. ROA, %
Neurocrine Biosciences. ROA, changes, pp
Neurocrine Biosciences (NBIX) ROA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROA, % | ? | 6.71% | 7.68% | 10.6% | 10.3% | 10.9% | 10.9% | |
| Changes by years, y/y, % | +4pp | +1pp | +8pp | +4pp | +4pp | |||
| Changes by quarters, q/q, % | 0pp | +1pp | +3pp | 0pp | +1pp | |||
